News & media

Here you can find our news and media resources. To comply with applicable regulation in Denmark, press releases and company announcements concerning specific medicinal products or investigational candidates in late-stage development are removed from our website within three weeks of publication. Please contact us to request a copy.

  • COMPANY ANNOUNCEMENT

    Zealand Pharma Announces Financial Results for the First Half of 2022

  • PRESS RELEASE

    Updated notice to holders of ADSs regarding termination of Deposit Agreement

  • COMPANY ANNOUNCEMENT

    Zealand Pharma Announces Voluntary Delisting of American Depositary Shares from the U.S.-Based Nasdaq Global Select Market

  • COMPANY ANNOUNCEMENT

    Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Second Quarter Results for 2022

  • COMPANY ANNOUNCEMENT

    Total number of shares and voting rights in Zealand Pharma at June 30, 2022

  • COMPANY ANNOUNCEMENT

    Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities

  • COMPANY ANNOUNCEMENT

    Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2022

  • PRESS RELEASE

    Zealand Pharma Presents Data from Phase 1 Trial of Dapiglutide at the 82nd Annual American Diabetes Association Scientific Sessions and Announces Dapiglutide to Move into Phase 2 Trial for Obesity

  • COMPANY ANNOUNCEMENT

    Zealand Pharma completes registration of capital increase

  • PRESS RELEASE

    Zealand Pharma to Participate in Upcoming Investor Conferences

  • PRESS RELEASE

    Zealand Pharma Announces Appointment of David M. Kendall, M.D., as Chief Medical Officer

  • COMPANY ANNOUNCEMENT

    Zealand Pharma announces directed issue and private placement corresponding to approx. 6.6 % of existing share capital

Corporate management

  • Adam ALR0640

    Adam Steensberg - President and Chief Executive Officer

  • Zealand Pharma 0285 FIN

    Adam Steensberg - President and Chief Executive Officer

  • Christina ALR0693 V2

    Christina Sonnenborg Bredal - Executive Vice President and Chief People Officer

  • David ALR1003

    David Kendall - Executive Vice President, Research & Development and Chief Medical Officer

  • Henriette ALR0758

    Henriette Wennicke - Executive Vice President and Chief Financial Officer

  • Ivan ALR0873

    Ivan Møller - Executive Vice President and Chief Operating Officer

  • Ravinder ALR0732

    Ravinder Chahil - Executive Vice President and General Counsel

Research and development

Logos and icons

Zealand Pharma 1503

Stay up-to-date with the latest news from Zealand

Sign-up to receive press releases and company announcements directly to your inbox

Subscribe to news

Investor and Media contacts

  • Anna ALR0858

    Anna Krassowska

    Vice President, Investor Relations & Corporate Communications

    Email Anna